AMB-CHMINACA

Legal status
Legal status	CA: Schedule II DE: NpSG (Industrial and scientific use only) UK: Class B
Identifiers
IUPAC name methyl (2S)-2-{[1-(cyclohexylmethyl)indazole-3-carbonyl]amino}-3-methylbutanoate
CAS Number	1863066-03-8(racemate)
PubChemCID	119026010
ChemSpider	32055578
UNII	OU56JJP891 Y21A13WADY(racemate)
CompTox Dashboard(EPA)	DTXSID601344891
Chemical and physical data
Formula	C21H29N3O3
Molar mass	371.481 g·mol−1
3D model (JSmol)	Interactive image
SMILES COC([C@H](C(C)C)NC(C1=NN(C2=C1C=CC=C2)CC3CCCCC3)=O)=O
InChI InChI=1S/C21H29N3O3/c1-14(2)18(21(26)27-3)22-20(25)19-16-11-7-8-12-17(16)24(23-19)13-15-9-5-4-6-10-15/h7-8,11-12,14-15,18H,4-6,9-10,13H2,1-3H3,(H,22,25)/t18-/m0/s1 Key:CRGGXDSTBHQLKJ-SFHVURJKSA-N

AMB-CHMINACA orMMB-CHMINACA (also known asMA-CHMINACA) is anindazole-basedsynthetic cannabinoid^[1] that is a potentagonist of theCB₁ receptor and has been sold online as adesigner drug.^[2][3][4]

AMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.^[5]

Sweden's public health agency classified AMB-CHMINACA as a narcotic substance, on January 18, 2019.^[6]

Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it.

• v
• t
• e

• Cannabinoids
• Designer drugs
• Indazolecarboxamides
• Cannabinoid stubs

• CS1 Swedish-language sources (sv)
• Articles with short description
• Short description matches Wikidata
• Short description is different from Wikidata
• Articles without EBI source
• Chemical pages without DrugBank identifier
• Articles without KEGG source
• Multiple chemicals in Infobox drug
• Multiple chemicals in an infobox that need indexing
• Drugs missing an ATC code
• Articles containing unverified chemical infoboxes
• All stub articles